H.U.Group Holdings,Inc.(4544) News

Application for Manufacturing and Marketing Authorization in Japan for Blood-Based IVD Test to Aid in Identifying Amyloid Pathology Associated with AD

Corporate Governance Report

[Summary] Consolidated Financial Results for the Six Months Ended September 30, 2025 (Under Japanese GAAP)

H.U.Group, First Half Ordinary Profit Turns to Profit

Notice Concerning the Status and Completion of the Acquisition of Treasury Stock

Notice Concerning the Status of the Acquisition of Treasury Stock

Introduction of the Stock Grant ESOP Trust

Notice Concerning Recording of Extraordinary Income Related to Sale of Non-current Assets and Shares, and Revision to Full-year Consolidated Earnings

H.U.Group, Net Income Forecast for the Fiscal Year Revised Upward by 27%

Notice Concerning Share Transfer of Care’x

Notice Concerning the Status of the Acquisition of Treasury Stock

[Summary] Consolidated Financial Results for the Three Months Ended June 30, 2025 (Under Japanese GAAP))

H.U.Group, Apr-Jun (1Q) Ordinary Profit Turns to Loss

Notice Concerning the Status of the Acquisition of Treasury Stock

Selected as Supplier Engagement Leader, CDP's Highest Rating in the Supplier Engagement Assessment

Notice Concerning the Status of the Acquisition of Treasury Stock

Corporate Governance Report

H.U. Group Holdings Continues to be Selected as a Constituent of the FTSE Blossom Japan Index and the FTSE Blossom Japan Sector Relative Index

【Delayed】Fujirebio Acquires Plasma Services Group and Strengthens Its Position As Provider of Critical and High Quality Raw Materials

Acquisition of "AAA," the Highest Rank, in the MSCI ESG Rating for the Fourth Consecutive Year